Comprehensive molecular characterization of urothelial bladder carcinoma Cancer Genome Atlas Research Network Nature 507 (7492), 315, 2014 | 2703 | 2014 |
BAP1 loss defines a new class of renal cell carcinoma S Peña-Llopis, S Vega-Rubín-de-Celis, A Liao, N Leng, A Pavía-Jiménez, ... Nature genetics 44 (7), 751-759, 2012 | 1014 | 2012 |
Targeting renal cell carcinoma with a HIF-2 antagonist W Chen, H Hill, A Christie, MS Kim, E Holloman, A Pavia-Jimenez, ... Nature 539 (7627), 112-117, 2016 | 682 | 2016 |
Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation P Kapur, S Peña-Llopis, A Christie, L Zhrebker, A Pavía-Jiménez, ... The lancet oncology 14 (2), 159-167, 2013 | 493 | 2013 |
Kidney cancer, version 3.2022, NCCN clinical practice guidelines in oncology RJ Motzer, E Jonasch, N Agarwal, A Alva, M Baine, K Beckermann, ... Journal of the National Comprehensive Cancer Network 20 (1), 71-90, 2022 | 452 | 2022 |
Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes S Durinck, EW Stawiski, A Pavía-Jiménez, Z Modrusan, P Kapur, ... Nature genetics 47 (1), 13-21, 2015 | 367 | 2015 |
A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer KH Chang, R Li, B Kuri, Y Lotan, CG Roehrborn, J Liu, R Vessella, ... Cell 154 (5), 1074-1084, 2013 | 350 | 2013 |
Isotope tracing of human clear cell renal cell carcinomas demonstrates suppressed glucose oxidation in vivo KD Courtney, D Bezwada, T Mashimo, K Pichumani, V Vemireddy, ... Cell metabolism 28 (5), 793-800. e2, 2018 | 243 | 2018 |
Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness … HS Jafri, S Chávez-Bueno, A Mejías, AM Gómez, AM Ríos, SS Nassi, ... Journal of Infectious Diseases 189 (10), 1856-1865, 2004 | 226 | 2004 |
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia K Trpkov, O Hes, SR Williamson, AJ Adeniran, A Agaimy, ... Modern Pathology 34 (7), 1392-1424, 2021 | 207 | 2021 |
A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma S Sivanand, S Peña-Llopis, H Zhao, B Kucejova, P Spence, ... Science translational medicine 4 (137), 137ra75-137ra75, 2012 | 203 | 2012 |
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia K Trpkov, SR Williamson, AJ Gill, AJ Adeniran, A Agaimy, ... Modern Pathology 34 (6), 1167-1184, 2021 | 177 | 2021 |
Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low‐risk clear cell renal cell carcinoma RW Joseph, P Kapur, DJ Serie, JE Eckel‐Passow, M Parasramka, T Ho, ... Cancer 120 (7), 1059-1067, 2014 | 172 | 2014 |
Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis SS Wang, YF Gu, N Wolff, K Stefanius, A Christie, A Dey, RE Hammer, ... Proceedings of the National Academy of Sciences 111 (46), 16538-16543, 2014 | 167 | 2014 |
Clear cell renal cell carcinoma subtypes identified by BAP1 and PBRM1 expression RW Joseph, P Kapur, DJ Serie, M Parasramka, TH Ho, JC Cheville, ... The Journal of urology 195 (1), 180-187, 2016 | 164 | 2016 |
SCINA: a semi-supervised subtyping algorithm of single cells and bulk samples Z Zhang, D Luo, X Zhong, JH Choi, Y Ma, S Wang, E Mahrt, W Guo, ... Genes 10 (7), 531, 2019 | 161 | 2019 |
Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade YF Gu, S Cohn, A Christie, T McKenzie, N Wolff, QN Do, ... Cancer discovery 7 (8), 900-917, 2017 | 159 | 2017 |
Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer S Wang, RK Kollipara, N Srivastava, R Li, P Ravindranathan, ... Proceedings of the National Academy of Sciences 111 (11), 4251-4256, 2014 | 158 | 2014 |
An empirical approach leveraging tumorgrafts to dissect the tumor microenvironment in renal cell carcinoma identifies missing link to prognostic inflammatory factors T Wang, R Lu, P Kapur, BS Jaiswal, R Hannan, Z Zhang, I Pedrosa, ... Cancer discovery 8 (9), 1142-1155, 2018 | 153 | 2018 |
HIF-2 complex dissociation, target inhibition, and acquired resistance with PT2385, a first-in-class HIF-2 inhibitor, in patients with clear cell renal cell carcinoma KD Courtney, Y Ma, A Diaz de Leon, A Christie, Z Xie, L Woolford, ... Clinical Cancer Research 26 (4), 793-803, 2020 | 152 | 2020 |